Reporting on methods in clinical trials

Area of Science:

• Clinical Trials Methodology
• Medical Research Publication Standards

Background:

• Adequate interpretation of clinical trials necessitates comprehensive reporting of study design and analysis methods.
• A significant gap exists in the transparent disclosure of crucial trial elements.

Purpose of the Study:

• To assess the frequency of reporting 11 essential design and analysis aspects in major medical journals.
• To identify deficiencies in clinical trial reporting to inform recommendations for improvement.

Main Methods:

• A systematic survey of 67 clinical trials published between July 1979 and June 1980 across four leading medical journals.
• Evaluation of the reporting completeness for 11 predefined critical items related to study design and data analysis.

Main Results:

• Overall, only 56% of the 11 important items were clearly reported across the surveyed clinical trials.
• While statistical analyses (80%) and random allocation (80%) were frequently mentioned, specific randomization methods (19%) and blinding of outcome assessment (30%) were poorly reported.
• Significant variation in reporting quality was observed across journals, with The New England Journal of Medicine performing best (71%) and The Lancet performing worst (46%).

Conclusions:

• Clinical trial reporting frequently lacks essential details, hindering proper interpretation and replication.
• Journal editors should implement guidelines to ensure comprehensive reporting of clinical trial design and analysis.
• Improving reporting standards is crucial for enhancing the reliability and validity of medical research findings.